Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma

OBJECTIVE: To evaluate the effectiveness of transarterial chemoembolization (TACE) combined with lenvatinib and sintilimab in treating patients with midstage hepatocellular carcinoma (HCC). METHODS: Sixty-two patients with midstage HCC were enrolled in this study. All of them were firstly treated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Menglong, Lai, Weiguo, Zhang, Jian, Hu, Bijuan, Huang, Liyin, Chu, Cunkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279099/
https://www.ncbi.nlm.nih.gov/pubmed/35845129
http://dx.doi.org/10.1155/2022/6957580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279099/
https://www.ncbi.nlm.nih.gov/pubmed/35845129
http://dx.doi.org/10.1155/2022/6957580

Ejemplares similares